Gaudium IVF & Women Health Shares List At ₹83 On NSE
By HDFC SKY | Published at: Feb 27, 2026 11:49 AM IST

Gaudium IVF & Women Health made its stock market debut at ₹83 per share on the NSE on February 27, 2026, reflecting a premium of 5.06% over its issue price of ₹79. As of 10:40 AM IST, the Gaudium IVF & Women Health share price was trading at ₹80.05, up 1.33% from the issue price, according to exchange data.
After opening above the issue price, the stock witnessed some profit booking in early trade. With the market still open, prices continue to move in line with ongoing buy and sell orders at the time of reporting.
Share Price Snapshot At 10:40 AM IST
As per exchange data at 10:40 AM IST, the Gaudium IVF & Women Health share price was at ₹80.05, translating into a gain of ₹1.05 per share over the issue price so far.
The stock is listed under NSE symbol GAUDIUMIVF and BSE scrip code 544709. The volume-weighted average price (VWAP) stood at ₹83.74 at the time of reporting, indicating active participation in early trades.
IPO Structure and Pricing Details
The ₹165 crore book-built public issue comprised a fresh issue of 1,13,92,500 shares aggregating to ₹90 crore and an offer for sale of 94,93,700 shares aggregating to ₹75 crore. The total issue size stood at 2,08,86,200 shares.
The price band was fixed at ₹75 to ₹79 per share, with the final issue price determined at ₹79 per share. The lot size for investors was 189 shares.
Post listing, the total outstanding shares increased to 7,27,86,884 shares from 6,13,94,384 shares prior to the issue.
Issue Management And Listing Details
Sarthi Capital Advisors Pvt. Ltd. acted as the book-running lead manager to the issue, while Bigshare Services Pvt. Ltd. served as the registrar.
The shares were admitted to trading on both NSE and BSE effective February 27, 2026. The stock continues to trade in the secondary market, with price levels subject to intraday fluctuations as the session progresses.
Source:
https://www.nseindia.com/get-quote/equity/GAUDIUMIVF/Gaudium-IVF-and-Women-Health-Limited
Disclaimer
If you have any concerns, questions, or wish to point out any discrepancies in our content, please feel free to write to us at content@hdfcsec.com.
Please Note: The information shared is intended solely for informational purposes and does not make any investment recommendations

